Background & Aim: Preeclampsia (PE) is the most common hypertensive disorder after 20 weeks of gestation, and its complications are the leading cause of maternal and fetal mortalities. Changes in the innate and adaptive immune systems play a crucial role in the pathogenesis of PE. Natural Killer Cells (NKTs) are the most abundant leukocytes during pregnancy, recruited and activated by ovarian hormones in the decidua. Recent evidence supports the idea that NKT cells exist in various environmental tissues and the decidua with their unique transcriptional profiles and cytokines, and bridge between innate and adaptive immune systems. Therefore, this study aimed to review the number, phenotype, changes, and functional function of NKT cells in normal pregnancy and preeclampsia. Materials & Methods: This study was a narrative review that utilized the PubMed-Medline and Embase databases to search for the role of NKT cells in pregnancy and preeclampsia. Data were obtained from searching and extracting relevant articles. Findings: The results of various studies showed that the number of NKT cells increases in preeclampsia compared to normal pregnancy. However, there isn't any significant difference in the quantity and characteristics of iNKT cells between normal pregnancy and preeclampsia. Nonetheless, normal pregnant women exhibit a slight but meaningful reduction in the secretion of IFN-γ from iNKT cells compared to women with preeclampsia. Discussion and Conclusion: NKT cells regulate the balance of Th1 and Th2 responses by secreting interleukin-4 and interferon-γ. During pregnancy, maternal immunity is biased towards the production of type 2 cytokines to inhibit the function of type 1 cytokines, which can be harmful to the developing fetus. This shift to type 2 cytokines occurs in normal pregnancy.